Clinical Trial Update: Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinorelbine tartrate and cyclophosphamide with either bevacizumab or temsirolimus in recurrent or refractory rhabdomyosarcoma has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Temsirolimus (temsirolimus)
• Vinorelbine tartrate (Vinorelbine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05